drugset / Trial / NCT02706977

The Effect of Dopamine on Diabetic Retinopathy

NCT02706977

Phase 1 Completed 60 enrolled Emory University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the use of electroretinogram (ERG) using a novel handheld system, RETeval, and evaluate contrast sensitivity testing in detecting pre-clinical retinopathy on a tablet device. Investigators also seek to assess if a medication called Sinemet™ CR can improve the electrical functions of the eye in participants with diabetes mellitus. This study will include a total of 45 participants; 30 with diabetes mellitus and 15 age-matched non-diabetic controls. Participants with diabetes mellitus and electroretinogram (ERG) delays will be randomized to a low or high dose Sinemet CR group.

Timeline

Start
2016-01
Primary completion
2019-08-15
Completion
2019-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown 25 mg Oral
Subject Carbidopa Unknown 50 mg Oral
Subject Levodopa Small molecule 100 mg Oral
Subject Levodopa Small molecule 200 mg Oral